Clinical Trial Update: Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200). [Phase 3]

View source ↗

Summary

Phase 3 trial comparing AMG 510 (sotorasib) with docetaxel in KRAS G12C-mutated advanced/metastatic non-small cell lung cancer has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AMG 510 (sotorasib) (sotorasib)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Amgen | Conditions: KRAS p, G12c Mutated /Advanced Metastatic NSCLC | Phase 3 | Status: COMPLETED | Results posted: 2023-05-10